How to read a vaccine study and Tobak et Al Ann Arbor influenza

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/4

encourage image

There's no tags or description

Looks like no tags are added yet.

5 Terms

1
New cards

what was the study of the Toback et al Vaccine paper

is the nasal spray flu vaccine (LAIV) safe for children age 24-59 months? bc an earlier study found more wheezing in younger kids

2
New cards

What was the methodology of the Toback et al: Vaccine

  • followed 28,000 LAIV vax kids @ kaiser from 2007-2010

  • excluded kids w asthma or high risk conditions

  • compared them to three groups: unvax kids, kids w injected flu short (TIV), and same kids at diff. time windows after vax

  • counted medical attended events (diagnosis tied to a medical visit), serious adverse events, and hospitalizations


3
New cards

What were the results of the Toback et al: Vaccine

  • Asthma/wheezing was not increased and was actually lower in most comparisons

  • No deaths, and serious adverse events were similar across groups

  • Of 4,696 comparisons, 1.8% showed higher rates after LAIV and 4.7% showed lower rates. There was no pattern suggesting a safety problem


4
New cards

what were caveats in the Toback et al: Vaccine paper

  • With so many comparisons, some “significant” results happen by chance

  • The study was sponsored by MedImmune, the vaccine’s maker

  • groups weren’t random


5
New cards

What is the key point the Raff blog post “How to read vaccine safety study” is trying to show

people should read beyond the title and abstract before criticizing a study